Zekeriya Keskin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zekeriya Keskin has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Mustafa Asım Gedikli
Department of İnternal Medicine, Faculty of Medicine, Sivas Cumhuriyet University, Sivas, Turkey
6 shared publications - Fatih Yulak
Cumhuriyet Üniversitesi
2 shared publications - Muhammed Faruk Aşkın
Sivas Cumhuriyet University, Department of Nephrology, Sivas, Türkiye
2 shared publications - Musa Polat
Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Sivas Cumhuriyet University, Sivas, Turkey
2 shared publications - Onur Büyüktekeli
Sivas Cumhuriyet University, Department of Nephrology, Sivas, Türkiye
2 shared publications - Burak Aydın
Sivas Cumhuriyet Üniversitesi Tıp Fakültesi, Ortopedi ve Travmatoloji Anabilim Dalı, Sivas
1 shared publication
Latest Publications
- Open Access
- 22 July 2026
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 52
Investigation of Uric Acid/HDL-Cholesterol Ratio as an Independent Risk Factor for Diabetic Nephropathy: A Cross-Sectional Study
Diabetic nephropathy (DN) is a major microvascular complication requiring early markers for risk stratification. We investigated the clinical utility of the uric acid (UA) to high density lipoprotein cholesterol (HDL-C) ratio (UHR) as a practical proinflammatory-prooxidative marker for DN. In this retrospective cross-sectional study, records of 934 patients with diabetes mellitus (DM) were analyzed. UHR was calculated as [UA/HDL] x 100. DN was defined based on the albumin-to-creatinine ratio (ACR) and/or estimated glomerular filtration rate (eGFR) criteria. Patients were evaluated according to the presence of nephropathy, stage of nephropathy, and albuminuria categories. ROC analysis was performed for UHR, UA and HDL-C. Factors associated with DN were evaluated using logistic regression analysis. UHR was significantly higher in patients with DN compared to those without DN (p
- 22 July 2026
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 52
Open AccessInvestigation of Uric Acid/HDL-Cholesterol Ratio as an Independent Risk Factor for Diabetic Nephropathy: A Cross-Sectional Study
Diabetic nephropathy (DN) is a major microvascular complication requiring early markers for risk stratification. We investigated the clinical utility of the uric acid (UA) to high density lipoprotein cholesterol (HDL-C) ratio (UHR) as a practical proinflammatory-prooxidative marker for DN. In this retrospective cross-sectional study, records of 934 patients with diabetes mellitus (DM) were analyzed. UHR was calculated as [UA/HDL] x 100. DN was defined based on the albumin-to-creatinine ratio (ACR) and/or estimated glomerular filtration rate (eGFR) criteria. Patients were evaluated according to the presence of nephropathy, stage of nephropathy, and albuminuria categories. ROC analysis was performed for UHR, UA and HDL-C. Factors associated with DN were evaluated using logistic regression analysis. UHR was significantly higher in patients with DN compared to those without DN (p
- 1 June 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (6) , 555-560
Evaluation of artificial intelligence chatbots in answering questions about unintentional weight loss: a comparative study
Aim Our study aims to evaluate the accuracy comparatively reliability of the responses provided by artificial intelligence (AI) chatbots ChatGPT, DeepSeek, and Gemini to clinical questions regarding a symptom with a multidisciplinary and broad differential diagnosis, such as unintentional weight loss (UWL). Methods 129 clinical questions, definitions, symptomatology, differential diagnosis, diagnostic approach, treatment and management, and patient questions compiled from various health websites, books, and guides were categorized under six main headings and directed to three different AI chatbots. Each chatbot was asked to score the difficulty level of each question, and the relationship between difficulty assessments and accuracy performance was analyzed. Each response was evaluated by three internal medicine specialists and scored 1–4 based on accuracy. Results ChatGPT and DeepSeek demonstrated similar performance with high accuracy rates, while Gemini performed at a significantly lower accuracy level. Significant differences were observed between the chatbots in five of the six question groups (p0.05). Conclusion While ChatGPT and DeepSeek offer high accuracy and reliability, Gemini has performed below these two AI chatbots. Our findings indicate that AI chatbots should not be used as standalone tools for diagnosis, treatment, and management in complex clinical decision-making processes. However, they can be considered an important complementary tool for rapid access to accurate information and supporting clinical decisions.
- 1 June 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (6) , 555-560
Evaluation of artificial intelligence chatbots in answering questions about unintentional weight loss: a comparative study
Aim Our study aims to evaluate the accuracy comparatively reliability of the responses provided by artificial intelligence (AI) chatbots ChatGPT, DeepSeek, and Gemini to clinical questions regarding a symptom with a multidisciplinary and broad differential diagnosis, such as unintentional weight loss (UWL). Methods 129 clinical questions, definitions, symptomatology, differential diagnosis, diagnostic approach, treatment and management, and patient questions compiled from various health websites, books, and guides were categorized under six main headings and directed to three different AI chatbots. Each chatbot was asked to score the difficulty level of each question, and the relationship between difficulty assessments and accuracy performance was analyzed. Each response was evaluated by three internal medicine specialists and scored 1–4 based on accuracy. Results ChatGPT and DeepSeek demonstrated similar performance with high accuracy rates, while Gemini performed at a significantly lower accuracy level. Significant differences were observed between the chatbots in five of the six question groups (p0.05). Conclusion While ChatGPT and DeepSeek offer high accuracy and reliability, Gemini has performed below these two AI chatbots. Our findings indicate that AI chatbots should not be used as standalone tools for diagnosis, treatment, and management in complex clinical decision-making processes. However, they can be considered an important complementary tool for rapid access to accurate information and supporting clinical decisions.
- Open Access
- 21 May 2026
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 21 (1)
Specialty-based differences in osteoporosis management in Türkiye: a national cross-sectional survey
Summary: This study showed significant specialty-based differences in osteoporosis management in Türkiye. Physical medicine and rehabilitation (PM&R) physicians demonstrated the highest awareness, whereas orthopedic physicians demonstrated the lowest. Guideline use, rather than seniority, was associated with better awareness, supporting targeted education and wider fracture liaison services (FLS) implementation. Purpose: This study aimed to compare adherence to current guidelines, clinical approaches, and awareness levels among physicians in internal medicine (IM), PM&R, and orthopedics and traumatology who are actively involved in osteoporosis management in Türkiye. Methods: A total of 447 physicians from across Türkiye were included (122 IM, 203 PM&R, and 122 orthopedic physicians). A questionnaire was used to evaluate approaches to diagnosis, treatment, and follow-up. An osteoporosis awareness score was calculated as the mean of guideline-based awareness items (Cronbach’s α = 0.890). Data were analyzed using the chi-square test, Kruskal-Wallis test, and multivariable linear regression. Results: Awareness scores differed significantly across specialties ( p < 0.001). The median (IQR) score was highest in PM&R physicians at 4.00 (3.75–4.25), followed by IM physicians at 3.50 (3.00–4.00) and orthopedic physicians at 2.88 (2.00–3.50). Significant between-specialty differences were also observed in diagnostic evaluation, pre-treatment laboratory assessment, denosumab preference, planning of treatment transition after discontinuation, and follow-up strategies (all p < 0.05). In multivariable regression analysis, specialty ( B = 0.782, p < 0.001) and active guideline use ( B = 0.344, p < 0.001) were the strongest independent predictors of awareness score, whereas years of professional experience and academic title were not significant. Conclusion: Osteoporosis management in Türkiye differs substantially by specialty. Lower concordance with guideline-based care among orthopedics and traumatology physicians may contribute to the treatment gap. Guideline-oriented education should therefore be prioritized over professional seniority, and multidisciplinary FLS should be further expanded.
- 21 May 2026
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 21 (1)
Open AccessSpecialty-based differences in osteoporosis management in Türkiye: a national cross-sectional survey
Summary: This study showed significant specialty-based differences in osteoporosis management in Türkiye. Physical medicine and rehabilitation (PM&R) physicians demonstrated the highest awareness, whereas orthopedic physicians demonstrated the lowest. Guideline use, rather than seniority, was associated with better awareness, supporting targeted education and wider fracture liaison services (FLS) implementation. Purpose: This study aimed to compare adherence to current guidelines, clinical approaches, and awareness levels among physicians in internal medicine (IM), PM&R, and orthopedics and traumatology who are actively involved in osteoporosis management in Türkiye. Methods: A total of 447 physicians from across Türkiye were included (122 IM, 203 PM&R, and 122 orthopedic physicians). A questionnaire was used to evaluate approaches to diagnosis, treatment, and follow-up. An osteoporosis awareness score was calculated as the mean of guideline-based awareness items (Cronbach’s α = 0.890). Data were analyzed using the chi-square test, Kruskal-Wallis test, and multivariable linear regression. Results: Awareness scores differed significantly across specialties ( p < 0.001). The median (IQR) score was highest in PM&R physicians at 4.00 (3.75–4.25), followed by IM physicians at 3.50 (3.00–4.00) and orthopedic physicians at 2.88 (2.00–3.50). Significant between-specialty differences were also observed in diagnostic evaluation, pre-treatment laboratory assessment, denosumab preference, planning of treatment transition after discontinuation, and follow-up strategies (all p < 0.05). In multivariable regression analysis, specialty ( B = 0.782, p < 0.001) and active guideline use ( B = 0.344, p < 0.001) were the strongest independent predictors of awareness score, whereas years of professional experience and academic title were not significant. Conclusion: Osteoporosis management in Türkiye differs substantially by specialty. Lower concordance with guideline-based care among orthopedics and traumatology physicians may contribute to the treatment gap. Guideline-oriented education should therefore be prioritized over professional seniority, and multidisciplinary FLS should be further expanded.
- 11 February 2026
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 48 (2) , 199-209
The Effect of the Covid-19 Pandemic Process on Hba1c In Type 2 Diabetes Patients Applying to the Internal Medicine Outpatient Clinic
The incidence and prevalence of Type 2 Diabetes Mellitus (DM) are increasing worldwide. Due to the restrictions, increased stress, and increased sedentary life during the pandemic, deterioration in diabetes control is expected. The aim of this study is to determine the effect of COVID-19 on HbA1c values and how it affects diabetes control. In our study, a total of 6217 diabetic patients were examined retrospectively in 5 separate periods (March 2018-February 2019, March 2019-February 2020, March 2020-February 2021, March 2021-February 2022, March 2022-February 2023). According to the HbA1c value; those with HbA1c values were classified as well-controlled, those between 7-9% as poorly controlled, and those >9% as very poorly controlled. In addition, LDL, HDL, cholesterol and fasting blood sugar values were recorded. There are significant differences between the groups in terms of HbA1c measurements (p<0.001). The lowest HbA1c value was found to be 7.61% in the measurement between March 2018 and February 2019, and the highest value was found to be 8.39% in the measurement between March 2020 and February 2021. The HbA1c very poor control rate was the highest in March 2020 and February 2021 (30.9%), and the good control rate was the highest in March 2018 and February 2019 (51.3%). In our study, HbA1c values and poorly controlled patient rates were found to be higher during the pandemic period. Considering this result, it can be said that the pandemic process caused deterioration in disease control in Type 2 diabetes patients.
- 11 February 2026
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 48 (2) , 199-209
The Effect of the Covid-19 Pandemic Process on Hba1c In Type 2 Diabetes Patients Applying to the Internal Medicine Outpatient Clinic
The incidence and prevalence of Type 2 Diabetes Mellitus (DM) are increasing worldwide. Due to the restrictions, increased stress, and increased sedentary life during the pandemic, deterioration in diabetes control is expected. The aim of this study is to determine the effect of COVID-19 on HbA1c values and how it affects diabetes control. In our study, a total of 6217 diabetic patients were examined retrospectively in 5 separate periods (March 2018-February 2019, March 2019-February 2020, March 2020-February 2021, March 2021-February 2022, March 2022-February 2023). According to the HbA1c value; those with HbA1c values were classified as well-controlled, those between 7-9% as poorly controlled, and those >9% as very poorly controlled. In addition, LDL, HDL, cholesterol and fasting blood sugar values were recorded. There are significant differences between the groups in terms of HbA1c measurements (p<0.001). The lowest HbA1c value was found to be 7.61% in the measurement between March 2018 and February 2019, and the highest value was found to be 8.39% in the measurement between March 2020 and February 2021. The HbA1c very poor control rate was the highest in March 2020 and February 2021 (30.9%), and the good control rate was the highest in March 2018 and February 2019 (51.3%). In our study, HbA1c values and poorly controlled patient rates were found to be higher during the pandemic period. Considering this result, it can be said that the pandemic process caused deterioration in disease control in Type 2 diabetes patients.
- 10 February 2026
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 52
Serum Cathepsin G Levels and Their Relationship with Glycemic and Inflammatory Markers in Type 2 Diabetes Mellitus
Cathepsin G (CatG), a neutrophil-derived serine protease, contributes to inflammation and vascular remodeling. Dysregulated CatG activity has been implicated in autoimmune and metabolic disorders; however, its role in type 2 diabetes mellitus (T2DM) remains insufficiently characterized. This cross-sectional study investigated serum CatG levels in 76 patients with T2DM and 37 healthy controls. CatG levels were measured using ELISA, and metabolic and inflammatory indices—including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune–inflammation index (SII), and triglyceride-to–high-density lipoprotein cholesterol ratio (TG/HDL)—were assessed. Serum CatG levels were significantly lower in patients with T2DM than in controls (685.6±480.8 vs. 995.4±721.9 pg/mL; p=0.011). In unadjusted analyses, T2DM was negatively associated with CatG levels (B=−309.8; p=0.008); however, this association was no longer statistically significant after adjustment for age, sex, waist circumference, and PLR (p=0.139), indicating attenuation of the crude between-group difference. These findings suggest that baseline demographic and anthropometric imbalances may partly contribute to the observed differences in CatG levels. Serum CatG levels were inversely correlated with HbA1c, fasting plasma glucose, and waist circumference, while no significant associations were observed with inflammatory indices. Despite evidence of low-grade inflammation in T2DM, CatG levels did not parallel NLR, PLR, or SII. Reduced serum CatG levels may therefore be associated with changes in the inflammatory milieu of chronic metabolic disorders rather than with a specific protective or adaptive mechanism. Overall, CatG provides descriptive insight into qualitative aspects of inflammation in long-standing diabetes and warrants further investigation in longitudinal studies.
- 10 February 2026
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 52
Serum Cathepsin G Levels and Their Relationship with Glycemic and Inflammatory Markers in Type 2 Diabetes Mellitus
Cathepsin G (CatG), a neutrophil-derived serine protease, contributes to inflammation and vascular remodeling. Dysregulated CatG activity has been implicated in autoimmune and metabolic disorders; however, its role in type 2 diabetes mellitus (T2DM) remains insufficiently characterized. This cross-sectional study investigated serum CatG levels in 76 patients with T2DM and 37 healthy controls. CatG levels were measured using ELISA, and metabolic and inflammatory indices—including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune–inflammation index (SII), and triglyceride-to–high-density lipoprotein cholesterol ratio (TG/HDL)—were assessed. Serum CatG levels were significantly lower in patients with T2DM than in controls (685.6±480.8 vs. 995.4±721.9 pg/mL; p=0.011). In unadjusted analyses, T2DM was negatively associated with CatG levels (B=−309.8; p=0.008); however, this association was no longer statistically significant after adjustment for age, sex, waist circumference, and PLR (p=0.139), indicating attenuation of the crude between-group difference. These findings suggest that baseline demographic and anthropometric imbalances may partly contribute to the observed differences in CatG levels. Serum CatG levels were inversely correlated with HbA1c, fasting plasma glucose, and waist circumference, while no significant associations were observed with inflammatory indices. Despite evidence of low-grade inflammation in T2DM, CatG levels did not parallel NLR, PLR, or SII. Reduced serum CatG levels may therefore be associated with changes in the inflammatory milieu of chronic metabolic disorders rather than with a specific protective or adaptive mechanism. Overall, CatG provides descriptive insight into qualitative aspects of inflammation in long-standing diabetes and warrants further investigation in longitudinal studies.
- Open Access
- 16 November 2025
- Published by Ivano-Frankivsk National Medical University in Galician Medical Journal
- Vol. 32 (4)
Polymyxin B-Associated Acute Kidney Injury: Risk Factors and Short-Term Outcomes in a Single-Center Retrospective Cohort
Introduction. Polymyxin B (PMB) and other antibiotics in the polymyxin group are known to be nephrotoxic. In recent years, due to the increasing prevalence of antibiotic resistance, they have become a frequent treatment option for infections caused by multidrug-resistant Gram-negative bacteria. Our study aims to comprehensively examine the nephrotoxic effects and clinical characteristics of PMB in patients receiving treatment without dose reduction. Methods. This study included 176 patients, who were divided into two groups based on the presence or absence of acute kidney injury (AKI). The groups were analyzed for nephrotoxicity, associated risk factors, mortality, and other clinical characteristics. Results. Gender, pathogen, site of infection, comorbidities, additional nephrotoxic agents, duration of antibiotic use, and mechanical ventilation status were not identified as risk factors for AKI development. However, advanced age was found to be associated with nephrotoxicity (OR = 1.024, 95% CI 1.001–1.047; p = 0.037). Additionally, the mortality rate was higher in the AKI group (p = 0.001), although no significant difference was observed in the survival analysis (p = 0.189). Conclusions. PMB is commonly used in critically ill patients, and PMB-associated AKI tends to develop early during treatment. While most clinical characteristics were not independently associated with AKI, advanced age was identified as a significant risk factor. Therefore, close monitoring of renal function is recommended throughout PMB therapy.
- 16 November 2025
- Published by Ivano-Frankivsk National Medical University in Galician Medical Journal
- Vol. 32 (4)
Open AccessPolymyxin B-Associated Acute Kidney Injury: Risk Factors and Short-Term Outcomes in a Single-Center Retrospective Cohort
Introduction. Polymyxin B (PMB) and other antibiotics in the polymyxin group are known to be nephrotoxic. In recent years, due to the increasing prevalence of antibiotic resistance, they have become a frequent treatment option for infections caused by multidrug-resistant Gram-negative bacteria. Our study aims to comprehensively examine the nephrotoxic effects and clinical characteristics of PMB in patients receiving treatment without dose reduction. Methods. This study included 176 patients, who were divided into two groups based on the presence or absence of acute kidney injury (AKI). The groups were analyzed for nephrotoxicity, associated risk factors, mortality, and other clinical characteristics. Results. Gender, pathogen, site of infection, comorbidities, additional nephrotoxic agents, duration of antibiotic use, and mechanical ventilation status were not identified as risk factors for AKI development. However, advanced age was found to be associated with nephrotoxicity (OR = 1.024, 95% CI 1.001–1.047; p = 0.037). Additionally, the mortality rate was higher in the AKI group (p = 0.001), although no significant difference was observed in the survival analysis (p = 0.189). Conclusions. PMB is commonly used in critically ill patients, and PMB-associated AKI tends to develop early during treatment. While most clinical characteristics were not independently associated with AKI, advanced age was identified as a significant risk factor. Therefore, close monitoring of renal function is recommended throughout PMB therapy.
- 12 November 2025
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 127 (2) , 724-733
Association Between Hepatorenal Index and Arterial Stiffness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
- 12 November 2025
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 127 (2) , 724-733
Association Between Hepatorenal Index and Arterial Stiffness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
- 31 August 2025
- Published by Ordu University in ODÜ Tıp Dergisi
- Vol. 12 (2) , 94-99
Metformin-Associated Lactic Acidosis: A Case Report
Metformin is a widely prescribed and effective oral antidiabetic agent used in the treatment of type 2 diabetes mellitus (DM). Although generally well tolerated, metformin-associated lactic acidosis (MALA) is a rare but potentially fatal complication, especially in the presence of predisposing risk factors. Herein, we present a case of MALA that developed after volume depletion related to bowel preparation for endoscopic procedures. A 56-year-old male patient with type 2 diabetes mellitus who was taking metformin presented with nausea, vomiting, and decreased urine output following endoscopy preparation. Laboratory tests revealed severe metabolic acidosis (pH: 7.05; HCO₃⁻: 8.9 mmol/L; lactate: 21 mmol/L) and severe renal dysfunction (creatinine: 11.91 mg/dL). The patient was diagnosed with MALA based on clinical and biochemical findings and underwent emergency hemodialysis and intensive intravenous hydration. After treatment, the patient's metabolic parameters improved rapidly and the need for dialysis disappeared. Outpatient follow-up revealed that renal function had returned to normal. This case underscores the potential risk of continuing metformin therapy during peri-procedural periods associated with volume depletion. The omission of pre-procedural discontinuation of metformin in our patient likely contributed to the development of life-threatening lactic acidosis. Early diagnosis and timely initiation of renal replacement therapy are critical for reducing mortality in MALA cases.
- 31 August 2025
- Published by Ordu University in ODÜ Tıp Dergisi
- Vol. 12 (2) , 94-99
Metformin-Associated Lactic Acidosis: A Case Report
Metformin is a widely prescribed and effective oral antidiabetic agent used in the treatment of type 2 diabetes mellitus (DM). Although generally well tolerated, metformin-associated lactic acidosis (MALA) is a rare but potentially fatal complication, especially in the presence of predisposing risk factors. Herein, we present a case of MALA that developed after volume depletion related to bowel preparation for endoscopic procedures. A 56-year-old male patient with type 2 diabetes mellitus who was taking metformin presented with nausea, vomiting, and decreased urine output following endoscopy preparation. Laboratory tests revealed severe metabolic acidosis (pH: 7.05; HCO₃⁻: 8.9 mmol/L; lactate: 21 mmol/L) and severe renal dysfunction (creatinine: 11.91 mg/dL). The patient was diagnosed with MALA based on clinical and biochemical findings and underwent emergency hemodialysis and intensive intravenous hydration. After treatment, the patient's metabolic parameters improved rapidly and the need for dialysis disappeared. Outpatient follow-up revealed that renal function had returned to normal. This case underscores the potential risk of continuing metformin therapy during peri-procedural periods associated with volume depletion. The omission of pre-procedural discontinuation of metformin in our patient likely contributed to the development of life-threatening lactic acidosis. Early diagnosis and timely initiation of renal replacement therapy are critical for reducing mortality in MALA cases.
- 26 August 2024
- Published by Ordu University in ODÜ Tıp Dergisi
A confusing situation in the clinic practice: Isolated maternal hypothyroxinemia
Isolated maternal hypothyroxinemia (IMH) is a common problem in the clinic. There is a normal maternal thyroid stimulating hormone (TSH) level with a low maternal free thyroxine (FT4) level. The aim of this review is to explain IMD in the light of current literature and to contribute to clinicians in the management of IMH. Iodine deficiency is the most important factor in etiology. The effects of IMH on the pregnant woman and the fetus are not clear. However, it is a serious concern among serious clinicians, especially considering the importance of the effect of thyroid hormones on fetal brain development. As for the treatment of IMH, the number of studies conducted is not sufficient and there is no consensus and evidence on levothyroxine treatment. However, there is a consensus on iodine supplementation and it is recommended to take 250 mg of iodine daily. As a result, IMH is a problem that should be taken seriously during pregnancy and care should be taken regarding its diagnosis and treatment. Additionally, more research is needed on the effects and treatment of IMH on pregnant and fetal health
- 26 August 2024
- Published by Ordu University in ODÜ Tıp Dergisi
A confusing situation in the clinic practice: Isolated maternal hypothyroxinemia
Isolated maternal hypothyroxinemia (IMH) is a common problem in the clinic. There is a normal maternal thyroid stimulating hormone (TSH) level with a low maternal free thyroxine (FT4) level. The aim of this review is to explain IMD in the light of current literature and to contribute to clinicians in the management of IMH. Iodine deficiency is the most important factor in etiology. The effects of IMH on the pregnant woman and the fetus are not clear. However, it is a serious concern among serious clinicians, especially considering the importance of the effect of thyroid hormones on fetal brain development. As for the treatment of IMH, the number of studies conducted is not sufficient and there is no consensus and evidence on levothyroxine treatment. However, there is a consensus on iodine supplementation and it is recommended to take 250 mg of iodine daily. As a result, IMH is a problem that should be taken seriously during pregnancy and care should be taken regarding its diagnosis and treatment. Additionally, more research is needed on the effects and treatment of IMH on pregnant and fetal health